Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells
about
Targeted chromosomal deletions in human cells using zinc finger nucleasesTargeted genome editing in human cells with zinc finger nucleases constructed via modular assemblyBioinformatic analysis of HIV-1 entry and pathogenesis.The biology of CCR5 and CXCR4Characterization of LEDGF/p75 genetic variants and association with HIV-1 disease progression.Emerging concepts and approaches for chemokine-receptor drug discovery.Direct observation of chemokine receptors 5 on T-lymphocyte cell surfaces using fluorescent metal nanoprobes 2: Approximation of CCR5 populations.Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmissionCCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmissionDopamine receptor-interacting protein 78 acts as a molecular chaperone for CCR5 chemokine receptor signaling complex organization.Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.Canadian consensus guidelines for the optimal use of maraviroc in the treatment of HIV-infected adults.Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.Partial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.Impact of chemotherapy for HIV-1 related lymphoma on residual viremia and cellular HIV-1 DNA in patients on suppressive antiretroviral therapy.A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.CD4+ T cells from elite suppressors are more susceptible to HIV-1 but produce fewer virions than cells from chronic progressors.Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression.CCR5Delta32 59537-G/A promoter polymorphism is associated with low translational efficiency and the loss of CCR5Delta32 protective effectsRegulation of CXCR4 signaling.Role for the conserved N-terminal cysteines in the anti-chemokine activities by the chemokine-like protein MC148R1 encoded by Molluscum contagiosum virus.Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptors.Modulation of chemokine receptor activity through dimerization and crosstalkAlternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection.CXCR4-dependent infection of CD8+, but not CD4+, lymphocytes by a primary human immunodeficiency virus type 1 isolate.Differential expression of the alternatively spliced OPRM1 isoform μ-opioid receptor-1K in HIV-infected individuals.Na+/H+ exchanger regulatory factor-1 is involved in chemokine receptor homodimer CCR5 internalization and signal transduction but does not affect CXCR4 homodimer or CXCR4-CCR5 heterodimer.Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.Detection of CXCR4 receptors on cell surface using a fluorescent metal nanoshell.The potent anti-HIV activity of CXCL12gamma correlates with efficient CXCR4 binding and internalizationCCR5Delta32 protein expression and stability are critical for resistance to human immunodeficiency virus type 1 in vivoRisk of HIV Infection and Lethality Are Decreased in CCR5del32 Heterozygotes: Focus Nosocomial Infection Study and Meta-analysis.Cord blood stem cell therapy for acquired immune deficiency syndrome.A naturally occurring splice variant of CXCL12/stromal cell-derived factor 1 is a potent human immunodeficiency virus type 1 inhibitor with weak chemotaxis and cell survival activities.Association of CCL5 and CCR5 gene polymorphisms with periodontitis in Taiwanese.A guide to chemokines and their receptors.
P2860
Q24653591-C9CC8475-4210-4ECE-B86F-466287612B63Q24655166-5D73842C-75C2-4AB9-A550-5840306070D7Q27693321-E635B2C1-375C-4D0D-AB97-C3FB21932648Q29012920-7FCEB693-4654-4477-A27F-536F88508949Q30424582-991AB4AA-CAEE-4FBE-AF5E-477F68A1A37CQ33763369-E15667BB-318F-42A6-AAE8-5E36942A24E2Q33831201-F9303BFE-A976-42D3-A868-6B599C9D1B76Q33987424-40EEB5D1-812C-4677-B0BB-2262C81C381EQ34108023-7D4870BD-F9BB-4071-90E0-17B75401EA28Q34344881-3684BCA8-0421-410C-B571-254E503D813FQ34367158-A9727265-A569-4C01-B04E-ECEEF70507F0Q34437126-7CFB31B0-027E-4BBE-B5DE-E9023E554B44Q34623149-5494CE14-7E99-4201-83A0-6E4E67186D5DQ35069318-4B7BDE5D-46ED-4FE2-A8FB-B385B4198D24Q35123201-D1001599-00D9-4EE8-AEB4-D5D0780889AAQ35191116-FF98CB53-A9ED-4D41-B1E9-0EFC9E336C78Q35216907-13278473-A5B6-4CB1-A931-24151B925E04Q35600919-8B614019-0ECB-4D4B-97BE-791963AFD60AQ36483857-576A69CF-21D2-4E64-B217-8E77DB926DF9Q36684219-A01BD1F9-1776-4A25-9423-8876A13BDC61Q37139789-C361CF3C-2285-4374-94E0-A8554B5DC5C9Q37185404-4AF93360-F9DF-40D1-A21A-68DA8AFF15A5Q37355817-1F305EAC-C1D1-418E-9B3E-097413E9BB38Q37463746-F1C1AB35-FB22-4700-B846-FD70FE474848Q37463869-1C8611EA-88FD-4ED8-83B5-357AEE9B340DQ37596922-D2236D73-6891-414F-8EF5-207A25ACDB2BQ37610922-98E3FC2E-CCA6-482E-9363-96E8A33BEBEFQ39043299-E8576C09-8584-47EA-B7D9-C408FB3EA590Q39376055-D99C2804-87C6-4692-A4E6-D82A962BC74EQ39600315-A1F186BD-418D-4B22-BA1C-39774E77FE08Q39762386-7A0C3F44-F391-47F1-A099-D5D1EB2D609AQ41860559-25F67E97-651F-4DAD-9057-4D3F3BAE4958Q42003237-412EE634-DBB6-47A5-A241-F436208249DAQ42071734-233B2083-5865-43B0-BAE6-95D58E1CD5FDQ42412940-BA823312-0E59-43AE-A82F-18003E462529Q54223996-F8A2F325-71B7-4D42-857E-E14F4C4A3EEEQ54238056-390EDF05-B7D5-4234-B898-4F91458C0B65
P2860
Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@ast
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@en
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@nl
type
label
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@ast
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@en
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@nl
prefLabel
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@ast
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@en
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@nl
P2093
P2860
P1433
P1476
Role for CCR5Delta32 protein i ...... s type 1 in primary CD4+ cells
@en
P2093
Ghalib Alkhatib
Ioan Vlad Nicolescu
Jin Qingwen
Lokesh Agrawal
Zainab VanHorn-Ali
P2860
P304
P356
10.1128/JVI.78.5.2277-2287.2004
P407
P577
2004-03-01T00:00:00Z